secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001753926-23-001534
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical terminates named executive officer Scott Dunbar in subsidiary workforce reduction
--------------------------------------------------------------------------------

- Scott Dunbar terminated without cause effective Nov 20, 2023 as part of Cortigent workforce reduction.
- Dunbar was a named executive officer in 2023 proxy and former Acting CEO of predecessor Second Sight Medical.
- Severance includes ~$70,000 cash payment and COBRA premium reimbursement for up to six months.
- Company intends to enter a separation and release agreement with Dunbar.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392623001534/0001753926-23-001534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392623001534/g083867_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer